Примери за използване на Described in table на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
If the infusion is well tolerated the infusion rate may be increased in a stepwise fashion as described in Table 3.
Interruption of dosing may be needed for management of laboratory abnormalities as described in Table 1.
persistent neutropenia and thrombocytopenia as described in Table 1.
then the dose of Vizimpro should be reduced as described in Table 1.
AST/ALT elevations may need to be managed with treatment interruption and/or dose reduction as described in Table 2(see section 4.2).
at a lower dose as described in table 2.
They all addressed Roma integration in at least some of their OPs, in the ways described in Table 4.
epoetin at the time of substitution as described in Table 1.
Division 3M includes that portion of Division 3L enclosed by lines joining the points described in Table 1 and depicted in Figure 1(1)
Fishing in the Regulatory Area shall be restricted to an area east of a line bound by the coordinates described in Table 3 and depicted in Figure 1(3)
then resumed at next lower dose level as described in Table 1 and not escalated to 180 mg once daily.
NOTE 2: The concrete can be a subject to more than one exposure, described in Table 1, and the conditions of the environment to which it is exposed,
tolerability are recommended as described in Table 1 and Table 2.
were randomised in a 2:1 ratio to receive one of the treatment regimens described in Table 8.
The initial total daily dose of Numient described in Table 1 above may need to be decreased by approximately 30% for patients converting specifically from levodopa/DDC inhibitor modified-release medicinal products to Numient.
are further described in Table 3 below.
asimilar pattern emerges to the one described in Table 3.1of Chapter 3,where 66% of all women researchers of the Enwise10 come from onlythree countries(Poland,
The haircuts applied to debt instruments included in categories I to IV differ according to the residual maturity and coupon structure of the debt instruments as described in Table 7 for eligible marketable fixed coupon
reduced or discontinued as described in Table 4(see sections 4.2,
reduced or discontinued as described in Table 3(see sections 4.2 and 4.8).